Clinical trial
Treatment of Hemochromatosis
NCT00007150 · National Institutes of Health Clinical Center (CC), NIH · Active, not recruiting
Key facts
| NCT number | NCT00007150 |
|---|---|
| Title | Treatment of Hemochromatosis |
| Official title | Studies of Phlebotomy Therapy in Hereditary Hemochromatosis |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Active, not recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hemochromatosis |
| Intervention type | Procedure |
| Interventions | Phlebotomy |
| Enrollment | 622 |
| Start date | Jan 1, 2001 |
| Primary completion | Dec 31, 2026 |
| Completion | Dec 31, 2026 |
| First posted | Dec 11, 2000 |
| Last update posted | Jan 16, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: